Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Evidence of gene-gene interaction and age-at-diagnosis effects in type 1 diabetes.

Howson JM, Cooper JD, Smyth DJ, Walker NM, Stevens H, She JX, Eisenbarth GS, Rewers M, Todd JA, Akolkar B, Concannon P, Erlich HA, Julier C, Morahan G, Nerup J, Nierras C, Pociot F, Rich SS; Type 1 Diabetes Genetics Consortium.

Diabetes. 2012 Nov;61(11):3012-7. doi: 10.2337/db11-1694. Epub 2012 Aug 13.

2.

LADA and T1D in Estonian population - two different genetic risk profiles.

Kisand K, Uibo R.

Gene. 2012 Apr 15;497(2):285-91. doi: 10.1016/j.gene.2012.01.089. Epub 2012 Feb 3.

PMID:
22326526
3.

Association analysis of PTPN22, CTLA4 and IFIH1 genes with type 1 diabetes in Colombian families.

Rodríguez A, Alfaro JM, Balthazar V, Pineda Trujillo N.

J Diabetes. 2015 May;7(3):402-10. doi: 10.1111/1753-0407.12192. Epub 2014 Sep 10.

PMID:
25042601
4.

Temporal trends of HLA, CTLA-4 and PTPN22 genotype frequencies among type 1 diabetes in Continental Italy.

Spoletini M, Zampetti S, Campagna G, Marandola L, Capizzi M, Buzzetti R; IMDIAB Study Group.

PLoS One. 2013 Apr 17;8(4):e61331. doi: 10.1371/journal.pone.0061331. Print 2013.

5.

PTPN22 Trp620 explains the association of chromosome 1p13 with type 1 diabetes and shows a statistical interaction with HLA class II genotypes.

Smyth DJ, Cooper JD, Howson JM, Walker NM, Plagnol V, Stevens H, Clayton DG, Todd JA.

Diabetes. 2008 Jun;57(6):1730-7. doi: 10.2337/db07-1131. Epub 2008 Feb 27.

6.

Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes.

Bjørnvold M, Undlien DE, Joner G, Dahl-Jørgensen K, Njølstad PR, Akselsen HE, Gervin K, Rønningen KS, Stene LC.

Diabetologia. 2008 Apr;51(4):589-96. doi: 10.1007/s00125-008-0932-0. Epub 2008 Feb 22.

7.

Genetics of Autoimmune Thyroiditis in Type 1 Diabetes Reveals a Novel Association With DPB1*0201: Data From the Type 1 Diabetes Genetics Consortium.

Kahles H, Fain PR, Baker P, Eisenbarth G, Badenhoop K.

Diabetes Care. 2015 Oct;38 Suppl 2:S21-8. doi: 10.2337/dcs15-2005.

9.

Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitis.

Carr EJ, Niederer HA, Williams J, Harper L, Watts RA, Lyons PA, Smith KG.

BMC Med Genet. 2009 Dec 1;10:121. doi: 10.1186/1471-2350-10-121.

10.

The PTPN22 1858T allele but not variants in the proximal promoter region of IL-21 gene is associated with the susceptibility to type 1 diabetes and the presence of autoantibodies in a Brazilian cohort.

Mainardi-Novo DT, Santos AS, Fukui RT, Gamberini M, Correia MR, Ruiz MO, Mangueira CL, Matioli SR, Vasconcelos DM, Silva ME.

Clin Exp Immunol. 2013 Apr;172(1):16-22. doi: 10.1111/cei.12030.

11.

Shared and distinct genetic variants in type 1 diabetes and celiac disease.

Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH, Howson JM, Stevens H, McManus R, Wijmenga C, Heap GA, Dubois PC, Clayton DG, Hunt KA, van Heel DA, Todd JA.

N Engl J Med. 2008 Dec 25;359(26):2767-77. doi: 10.1056/NEJMoa0807917. Epub 2008 Dec 10.

12.

Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1).

Butty V, Campbell C, Mathis D, Benoist C; DPT-1 Study Group.

Diabetes. 2008 Sep;57(9):2348-59. doi: 10.2337/db07-1736. Epub 2008 Jun 12.

13.

Association of variants in HLA-DQA1-DQB1, PTPN22, INS, and CTLA4 with GAD autoantibodies and insulin secretion in nondiabetic adults of the Botnia Prospective Study.

Andersen MK, Lundgren V, Isomaa B, Groop L, Tuomi T.

Eur J Endocrinol. 2012 Jul;167(1):27-33. doi: 10.1530/EJE-12-0023. Epub 2012 Apr 16.

14.

Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study.

Karlson EW, Chibnik LB, Cui J, Plenge RM, Glass RJ, Maher NE, Parker A, Roubenoff R, Izmailova E, Coblyn JS, Weinblatt ME, Shadick NA.

Ann Rheum Dis. 2008 Mar;67(3):358-63. Epub 2007 Jul 31.

15.

A novel single nucleotide polymorphism in the protein tyrosine phosphatase N22 gene (PTPN22) is associated with Type 1 diabetes in a Chinese population.

Pei Z, Chen X, Sun C, Du H, Wei H, Song W, Yang Y, Zhang M, Lu W, Cheng R, Luo F.

Diabet Med. 2014 Feb;31(2):219-26. doi: 10.1111/dme.12331. Epub 2013 Oct 21.

PMID:
24117662
16.

The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3.

Petrone A, Suraci C, Capizzi M, Giaccari A, Bosi E, Tiberti C, Cossu E, Pozzilli P, Falorni A, Buzzetti R; NIRAD Study Group.

Diabetes Care. 2008 Mar;31(3):534-8. Epub 2007 Dec 4.

PMID:
18056891
17.

Targeted Deep Sequencing in Multiple-Affected Sibships of European Ancestry Identifies Rare Deleterious Variants in PTPN22 That Confer Risk for Type 1 Diabetes.

Ge Y, Onengut-Gumuscu S, Quinlan AR, Mackey AJ, Wright JA, Buckner JH, Habib T, Rich SS, Concannon P.

Diabetes. 2016 Mar;65(3):794-802. doi: 10.2337/db15-0322. Epub 2015 Dec 2.

18.

Assessment of type 1 diabetes risk conferred by HLA-DRB1, INS-VNTR and PTPN22 genes using the Bayesian network approach.

Portuesi R, Pozzilli P, Boehm B, Buzzetti R, Filippi S.

PLoS One. 2013 Nov 18;8(11):e79506. doi: 10.1371/journal.pone.0079506. eCollection 2013.

19.

Genetic susceptibility factors of Type 1 diabetes in Asians.

Park Y, Eisenbarth GS.

Diabetes Metab Res Rev. 2001 Jan-Feb;17(1):2-11. Review.

PMID:
11241886
20.

The association between the PTPN22 1858C>T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies.

Maziarz M, Janer M, Roach JC, Hagopian W, Palmer JP, Deutsch K, Sanjeevi CB, Kockum I, Breslow N, Lernmark A; Swedish Childhood Diabetes Register; Diabetes Incidence in Sweden Study Group.

Genes Immun. 2010 Jul;11(5):406-15. doi: 10.1038/gene.2010.12. Epub 2010 May 6.

Supplemental Content

Support Center